Prosecution Insights
Last updated: April 19, 2026

Centessa Pharmaceuticals (Uk) Limited

4 pending office actions

Portfolio Summary

4
Total Pending OAs
1
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17909162 HETEROCYCLE CONTAINING STAT INHIBITORS AND COMPOSITIONS ROMERO, KRISTEN WANG 1624 Non-Final OA Jul 06, 2023
18024236 MEDIUM- OR MACRO-CYCLIC BENZYL-SUBSTITUTED HETEROCYCLE DERIVATIVES AND THEIR USES AS OREXIN-2 RECEPTOR AGONISTS WILLIS, DOUGLAS M 1624 Non-Final OA Mar 01, 2023
18024159 STAT INIHIBITORY COMPOUNDS AND COMPOSITIONS SHOWALTER, ALEXANDER KEITH 1629 Non-Final OA Mar 01, 2023
17610899 ACTIVATABLE BISPECIFIC ANTIBODIES COMPRISING A LINKER BETWEEN THE TWO BINDING DOMAINS WHICH IS A HUMAN IMMUNOGLOBULIN HINGE REGION, OR A VARIANT THEREOF, AND USES THEREOF LUNDE, GRACE HENRY 1641 Final Rejection Nov 12, 2021

Managing Centessa Pharmaceuticals (Uk) Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month